© 2017 Medpharm. Psychosis is an umbrella term used in the description of various conditions involving delusions and hallucinations. This article focuses mainly on the management of schizophrenia. Schizophrenia is a complex disorder, which provides many pharmacotherapy-related challenges. Advances have been made in the treatment of the condition; however, this requires a team approach, with the pharmacist having to monitor treatment both for safety and efficacy. The involvement of medicines that might modulate the N-methyl-D-aspartate (NMDA) receptors is an exciting development that should be monitored.
|Number of pages||8|
|Journal||SA Pharmaceutical Journal|
|Publication status||Published - 1 Jan 2017|
- First-generation antipsychotics
- Second-generation antipsychotics